BeOne Medicines (BEIGF) Debt Ratio (2015 - 2026)

BeOne Medicines (BEIGF) has 12 years of Debt Ratio data on file, last reported at 0.13 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.13, down 20.24% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.13 (down 20.24% YoY), and the FY2025 annual result was 0.12, down 27.61% from the prior year.
• Debt Ratio climbed to 0.13 in Q1 2026 per BEIGF's latest filing, from 0.12 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.22 in Q3 2025 and troughed at 0.04 in Q4 2022.
• A 5-year average of 0.13 and a median of 0.13 in 2026 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio slumped 48.28% in 2022, then jumped 299.97% in 2023.
• A 5-year view of Debt Ratio shows it stood at 0.04 in 2022, then jumped by 299.97% to 0.15 in 2023, then increased by 12.66% to 0.17 in 2024, then dropped by 27.61% to 0.12 in 2025, then grew by 1.32% to 0.13 in 2026.
• Business Quant data shows BEIGF's Debt Ratio at 0.13 in Q1 2026, 0.12 in Q4 2025, and 0.22 in Q3 2025.